The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas (Q40436271)

20 September 2017

title

The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas (English)

1 reference

20 September 2017

0 references

Young Saing Kim

1

1 reference

20 September 2017

Sung Yong Oh

2

1 reference

20 September 2017

Se-Il Go

3

1 reference

20 September 2017

Jung-Hun Kang

4

1 reference

20 September 2017

Inkeun Park

5

1 reference

20 September 2017

Haa-Na Song

6

1 reference

20 September 2017

Jun Ho Ji

7

1 reference

20 September 2017

In Gyu Hwang

8

1 reference

20 September 2017

Joung-Soon Jang

9

1 reference

20 September 2017

publication date

7 December 2016

1 reference

Cancer Chemotherapy and Pharmacology

20 September 2017

published in

1 reference

20 September 2017

volume

79

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

99-106

1 reference

20 September 2017

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Diagnosis and treatment of cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Prognostic Factors of Cholangiocarcinoma After Surgical Resection: A Retrospective Study of 293 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Radiation therapy, chemotherapy and chemoradiation in hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

Biliary Tract Cancers: Finding Better Ways to Lump and Split

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00280-016-3206-4

10.1007/S00280-016-3206-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1020976783

0 references

1 reference